Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase
暂无分享,去创建一个
Kuo-Chen Chou | Qishi Du | Dongqing Wei | Suzanne Sirois | K. Chou | Dongqing Wei | S. Sirois | Shu-Qing Wang | Shuqing Wang | Q. Du
[1] K. Chou. Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.
[2] K. Chou,et al. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide , 2004, Peptides.
[3] Kuo-Chen Chou,et al. Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points , 2004, J. Chem. Inf. Model..
[4] K. Nakagaki,et al. N-Terminal Domain of the Murine Coronavirus Receptor CEACAM1 Is Responsible for Fusogenic Activation and Conformational Changes of the Spike Protein , 2004, Journal of Virology.
[5] K. Shortridge. Severe acute respiratory syndrome and influenza: virus incursions from southern China. , 2003, American journal of respiratory and critical care medicine.
[6] G. Gao,et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] Feng Gao,et al. Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes , 2003, FEBS Letters.
[8] Kuo-Chen Chou,et al. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.
[9] Ren Zhang,et al. ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes , 2003, Biochemical and Biophysical Research Communications.
[10] Rolf Hilgenfeld,et al. Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.
[11] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[12] J. A. Comer,et al. A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[13] Kuo-Chen Chou,et al. Identification of the N‐terminal functional domains of Cdk5 by molecular truncation and computer modeling , 2002, Proteins.
[14] C. Soto,et al. Converting a peptide into a drug: strategies to improve stability and bioavailability. , 2002, Current medicinal chemistry.
[15] Kuo-Chen Chou,et al. Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .
[16] Kuo-Chen Chou,et al. Prediction of the tertiary structure of the beta-secretase zymogen. , 2002, Biochemical and biophysical research communications.
[17] K. Chou,et al. Prediction of the tertiary structure of a caspase‐9/inhibitor complex , 2000, FEBS letters.
[18] K D Watenpaugh,et al. A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.
[19] Junying Yuan,et al. Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.
[20] Gerhard Wagner,et al. Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.
[21] K. Chou,et al. Prediction of the tertiary structure and substrate binding site of caspase‐8 , 1997, FEBS letters.
[22] Æleen Frisch,et al. Exploring chemistry with electronic structure methods , 1996 .
[23] K. Chou. Prediction of human immunodeficiency virus protease cleavage sites in proteins. , 1996, Analytical biochemistry.
[24] K. Chou,et al. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. , 1993, The Journal of biological chemistry.
[25] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[26] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[27] Dm Jones,et al. H-77: a potent new renin inhibitor. In vitro and in vivo studies , 1982 .